The comparison the effect of flaxseed and Conjugated Estrogen vaginal cream in vaginal atrophy and sexual satisfaction of postmenopausal women.

Mashhad University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新: 2019年1月29日

试验速览

暂无简介。

•Having a willingness to participated in the study
•Married and have sexual activity
•age range of 40-65 years
•Have literacy to read and write
•Amenorrhoea has been followed for at least 12 months or 6 months amenorrhoea with FSH> 40.
•Have normal Pap smear in the past 3 years
•Clinic diagnosis of vaginal atrophy through a set of criteria including: score 65 or more (based on the VAS visual criteria) of the scale of the most vaginal annoyance symptoms (MBS) and having at least 2 signs of the descriptive evaluation table of vaginal mucus, PH> 5 and VMV=55 (vaginal maturation grade).

•Abnormal bleeding vaginal (pink to brown spotting or clear bleeding).
•have chronic illness such as diabetes, arthritis, cardiovascular disease, active liver disease or gallbladder disease.
•having vaginal infection
•allergy to estrogen or flax seed compounds
•don't suffering of endometrial cancer or breast cancer
•Endometrial cancer or breast cancer known or suspected .
•Consumer Products hormonal vaginal or transdermal than 4 weeks prior to the study and use of oral estrogen, uterine progesterone 8 weeks before the study and use of implants progesterone and estrogen injections for 3 months and pellets of estrogen and progesterone injections 6 months prior to the study to be

发起方